13-15mg/kg/d ursodeoxycholic    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
93原発性胆汁性胆管炎[原発性胆汁性肝硬変 (~2017.3)]1

93. 原発性胆汁性胆管炎[原発性胆汁性肝硬変 (~2017.3)] [臨床試験数:230,薬物数:215(DrugBank:51),標的遺伝子数:34,標的パスウェイ数:107
Searched query = "Primary biliary cholangitis", "Primary biliary cirrhosis", "PBC"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 230 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03345589
(ClinicalTrials.gov)
January 30, 20186/11/2017A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary CholangitisA Randomized Controlled Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary CholangitisPrimary Biliary CholangitisDrug: 18-22mg/kg/d Ursodeoxycholic;Drug: 13-15mg/kg/d UrsodeoxycholicWest China HospitalNULLUnknown status18 Years70 YearsAll40Phase 4China